Key Facts
- Hippocrates Holding was founded in March 2018 by two young professionals who left their careers in the investment world to launch a new entrepreneurial initiative in the healthcare business banking on the recent deregulation of the pharmacy market which allowed for the creation of real build up groups
- Supported by a group of Italian financial investors among which Buono Ventures, Hippocrates is the first Italian “independent” company in the pharmaceutical sector with the aim to consolidate the single pharmacy shop into a group
- As of today the company manages 120 owned pharmacies, in the center-north of Italy developing a turnover of over 200 € million euros and more than 600 employees (of which 300 pharmacists)
Key value creation pillars:
- Become the largest and most respected Pharmacy group in Northern Italy
- Improve supply chain and margins by consolidating negotiation with key suppliers
- Improve commercial policies and assortment to increase traffic and profitability
- Become target of choice for any large international pharmacy group willing to enter the Italian market
Exit:
- In November 2020 the company has been sold to Antin Infrastructure with the aim to continue to consolidate the Italian pharmacy market under the Hippocrates umbrella. In 2019 the company reached more than 200 € million sales, 40 € million EBITDA with a network of more than 120 pharmacies, thanks to the support given by the club deal investors, including Buono Ventures, in the first round
